Benzimidazole anthelmintic
This page covers all Benzimidazole anthelmintic drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting β-tubulin, glutamate-gated chloride channel.
Targets
β-tubulin · glutamate-gated chloride channel
Marketed (1)
- Administration of Albendazole on Day 1 · London School of Hygiene and Tropical Medicine · Infectious Disease / Parasitology
Albendazole inhibits microtubule polymerization in parasitic worms by binding to β-tubulin, disrupting their cellular structure and causing paralysis and death.
Phase 3 pipeline (4)
- emodepside (BAY 44-4400) · Swiss Tropical & Public Health Institute · Parasitology
Emodepside is a benzimidazole anthelmintic that acts as a glutamate-gated chloride channel agonist. - Mebendazole polymorph C · University of Kelaniya · Infectious Disease / Parasitology
Mebendazole polymorph C inhibits microtubule assembly in parasitic worms by binding to β-tubulin, disrupting their motility and nutrient uptake. - Albendazole on Day 1 · Lihir Medical Centre · Infectious Disease / Parasitology
Albendazole inhibits microtubule polymerization in parasitic worms by binding to β-tubulin, disrupting their cytoskeletal structure and causing paralysis and death. - Albendazole Pill · Universidad Nacional de Salta · Infectious Disease / Parasitology
Albendazole inhibits microtubule polymerization in parasitic worms by binding to β-tubulin, disrupting their cellular structure and causing paralysis and death.
Patent intelligence
- benzimidazole anthelmintic patent landscape — aggregated cliff calendar, attackable patents, originator estates